Intralymphatic allergen-specific immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intralymphatic allergen-specific immunotherapy, covering 2018-08-20 to 2018-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy [Phase 2, Phase 3]